🕵️ BATH & BODY Works, Inc. ($BBWI)
SEC insider & ownership activity, last 12 months · CIK 701985 · every row links its SEC filing
Over the last 12 months insiders bought $1.0M with no open-market selling against it. Symancyk James Kevin bought $351K in discretionary trades (Nov). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
6 buyers, $1.0M (6 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Symancyk James Kevin | 1 | $351K | 0 | – | Nov 24, 2025 |
| Steven E. Voskuil | 1 | $301K | 0 | – | Nov 21, 2025 |
| Sarah E. Nash | 1 | $156K | 0 | – | Nov 24, 2025 |
| Stephen D. Steinour | 1 | $100K | 0 | – | Nov 21, 2025 |
| Hondal Francis | 1 | $50K | 0 | – | Nov 21, 2025 |
| Brady Lucy | 1 | $50K | 0 | – | Nov 21, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| FMR LLC | 10.4% | 13G | Apr 7, 2026 | filing ↗ | |
| Abigail P. Johnson | 10.4% | 13G | Apr 7, 2026 | filing ↗ | |
| Blackrock, Inc. | 8.8% | 13G | Apr 17, 2025 | filing ↗ | |
| Vanguard Portfolio Management | 7.5% | 13G | Apr 29, 2026 | filing ↗ | |
| AQR Capital Management, LLC | 5.6% | 13G | Feb 13, 2026 | filing ↗ | |
| AQR Capital Management Holdings, LLC | 5.6% | 13G | Feb 13, 2026 | filing ↗ | |
| Vanguard Capital Management | 5.3% | 13G | Apr 29, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Reg FD disclosure (7.01) | Jul 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 20, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 11, 2026 | filing ↗ |
| Earnings (2.02) | May 20, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 4, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 3, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |
| Earnings (2.02) | Nov 20, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Nov 20, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 20, 2025 | filing ↗ |
| Earnings (2.02) | Aug 28, 2025 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 28, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 28, 2025 | filing ↗ |